{
    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
    "node_type": "fieldset",
    "children": [
        {
            "label": "Start of therapy",
            "outcome": "Initial Authorization for Wegovy™ (semaglutide) may be granted for 6 months when the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "smart_engine": "initiation",
            "children": [
                {
                    "label": "Body mass index (BMI) requirements:",
                    "node_type": "checkbox",
                    "node_value": false,
                    "children": [
                        {
                                    "label": "Document all the weight-related comorbid conditions the patient has (at least one required):",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Established cardiovascular disease or stroke",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Hypertension",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Type 2 diabetes (DM)",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Chronic kidney disease (CKD)",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Congenital heart disease (CHD)",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Obstructive sleep apnea",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Polycystic ovarian syndrome",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Dyslipidemia",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Non-alcoholic fatty liver disease",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Idiopathic intracranial hypertension",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Osteoarthritis in weight-bearing joints",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        }
                                    ]
            ]
        },
        {
            "label": "Continuation of therapy",
            "outcome": "Reauthorization for Wegovy™ (semaglutide) may be granted for an additional 6-month SA when the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "smart_engine": "continuation",
            "children": [
                {
                    "label": "Document the member has achieved a weight loss of at least 5% of baseline weight",
                    "node_type": "checkbox",
                    "node_value": false
                },
                {
                    "label": "Document the member’s BMI is > 24",
                    "node_type": "checkbox",
                    "node_value": false
                }
            ]
        }
    ]
}
